Our Pricing

Mounjaro All Doses Available - 2.5mg to 15mg

Published on: June 03, 2026

Finding Mounjaro all doses available uk can be challenging during periods of supply constraint, but Cured Pharmacy maintains stock across the complete licensed range—from the 2.5mg starter dose through to the maximum 15mg maintenance pen. As a UK-registered online pharmacy (GPhC 9012511), we provide transparent upfront pricing from £135.00 free clinical consultations with UK prescribers, and discreet next-day delivery across England, Scotland, Wales, and Northern Ireland.

Why Mounjaro All Doses Available Matters for Your Treatment Journey

Mounjaro (tirzepatide) requires careful dose escalation to minimise gastrointestinal side effects whilst optimising weight loss outcomes [1]. The MHRA-approved titration schedule begins at 2.5mg weekly for four weeks, increasing to 5mg, then 7.5mg, 10mg, 12.5mg, and finally 15mg—each step maintained for at least four weeks to allow your body to adapt [1].

Interrupted dose progression can compromise treatment efficacy and increase the risk of nausea, vomiting, and diarrhoea when restarting [2]. Access to the complete dose range ensures uninterrupted treatment continuity, which clinical data from the SURMOUNT-1 trial demonstrates is essential for achieving the average 22.5% body weight reduction observed over 72 weeks [1].

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team prioritise stock management across all six Mounjaro doses, so your treatment plan isn't disrupted by supply gaps that affect many UK pharmacies.

Understanding the Mounjaro Dose Escalation Schedule

Tirzepatide's dual GIP/GLP-1 receptor agonist mechanism requires gradual dose increases to balance efficacy with tolerability [1]. The structured escalation protocol allows your gastrointestinal system to adapt to slowed gastric emptying and enhanced satiety signalling—the primary mechanisms driving weight loss [3].

Most patients reach their optimal maintenance dose between 10mg and 15mg weekly, though some achieve their weight loss goals at lower doses [2]. Your UK prescriber will review your progress at each stage, assessing weight loss velocity, side effect profile, and metabolic markers to determine the appropriate pace of escalation.

Skipping doses or extending intervals beyond the recommended four-week periods can reduce treatment effectiveness. Clinical trial data shows that consistent weekly dosing at the prescribed strength produces significantly better outcomes than irregular administration patterns [1][2].

What Each Dose Achieves

The 2.5mg and 5mg doses serve primarily as initiation therapy, priming GIP and GLP-1 receptors whilst minimising initial side effects. Weight loss during these early weeks is typically modest—around 2-4% of body weight [1]. The 7.5mg and 10mg doses represent the therapeutic range where most patients begin experiencing substantial appetite suppression and accelerated weight loss. The 12.5mg and 15mg maintenance doses deliver maximum efficacy, with SURMOUNT-1 participants on 15mg achieving average reductions of 22.5% total body weight over 72 weeks [1].

How Mounjaro Compares to Other Weight Loss Treatments

Tirzepatide's dual-agonist mechanism distinguishes it from single-pathway GLP-1 treatments like semaglutide (Wegovy) and liraglutide (Saxenda) [3]. By activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, Mounjaro produces greater weight loss and improved glycaemic control compared to GLP-1 monotherapy [1][2].

Head-to-head trial data from SURPASS-2 demonstrated that tirzepatide 15mg produced superior weight reduction compared to semaglutide 1mg, with patients losing an additional 5-7% body weight on average [2]. Both medications require weekly injections and similar dose escalation protocols, but tirzepatide's dual mechanism appears to enhance satiety signalling and energy expenditure more effectively [3].

Older weight loss medications like orlistat (Xenical, Alli, Orlos) work through fat absorption inhibition rather than appetite regulation, typically producing 5-10% weight loss—significantly less than injectable GLP-1 treatments [4]. Your UK prescriber will recommend the most appropriate option based on your BMI, medical history, previous treatment responses, and personal preferences regarding administration method and frequency.

Mounjaro Pricing and Value at Cured Pharmacy

Mounjaro is available at Cured Pharmacy from £124.99 per four-week supply, with transparent pricing displayed before your free online consultation. Unlike some UK pharmacies that reveal costs only after assessment, we believe in upfront transparency so you can make informed decisions about your weight loss treatment.

The price varies depending on your prescribed dose strength, as higher-dose pens contain more active tirzepatide. Our lowest price guarantee ensures you're receiving competitive UK pricing without compromising on pharmaceutical quality—all Mounjaro supplied by Cured Pharmacy is genuine, UK-licensed medication sourced through MHRA-approved distribution channels.

Many patients find the investment worthwhile when considering the average 22.5% body weight reduction achieved in clinical trials, alongside improvements in cardiovascular risk markers, blood pressure, and metabolic health [1]. Your UK prescriber will discuss expected treatment duration during your consultation, as most patients require 12-18 months of therapy to reach and stabilise at their goal weight.

What's Included in Your Mounjaro Service

Every Mounjaro prescription from Cured Pharmacy includes a comprehensive clinical assessment by a UK-registered prescriber (completed online in under three minutes), pharmaceutical dispensing by our GPhC-registered team, discreet packaging with no external pharmacy branding, and next-day delivery across the UK. Follow-up consultations are included at no additional charge when you need to progress to your next dose or discuss side effects with your prescriber.

Starting Your Mounjaro Treatment: The Clinical Assessment Process

All Mounjaro prescriptions require clinical approval from a UK-registered prescriber, as tirzepatide is a prescription-only medication under MHRA regulations. Our online consultation takes under three minutes and covers your medical history, current medications, weight loss goals, previous treatment attempts, and any contraindications that might affect prescribing decisions.

Your prescriber will assess whether Mounjaro is appropriate based on your BMI (typically ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities), cardiovascular risk profile, history of pancreatitis or medullary thyroid carcinoma, and concurrent medications that might interact with tirzepatide [1]. If approved, your prescription is sent electronically to our pharmacy team for same-day dispensing.

You'll receive detailed administration instructions with your first Mounjaro pen, including injection technique, site rotation guidance (abdomen, thigh, or upper arm), storage requirements (refrigerate unused pens at 2-8°C), and what to expect during your first month. Our clinical team remains available via phone (+44 116 4646009) throughout your treatment for any questions or concerns about side effects, dose progression, or injection technique.

Managing Side Effects and Optimising Mounjaro Results

The most common Mounjaro side effects are gastrointestinal—nausea, diarrhoea, vomiting, constipation, and abdominal discomfort—affecting 20-40% of patients during dose escalation [1][2]. These symptoms typically peak within 2-3 days of injection and diminish as your body adapts, with severity decreasing significantly at stable maintenance doses [2].

Clinical strategies to minimise side effects include eating smaller, more frequent meals, avoiding high-fat foods that slow gastric emptying further, staying well-hydrated, and taking your weekly injection on the same day each week (consistency reduces GI fluctuations) [3]. If side effects become intolerable, your prescriber may recommend extending your current dose phase for an additional four weeks before escalating, or in rare cases, stepping back to the previous dose temporarily [2].

Optimising weight loss outcomes requires combining Mounjaro with sustainable lifestyle modifications—clinical trial participants received nutritional counselling and were encouraged to maintain a 500-calorie daily deficit alongside 150 minutes of moderate-intensity exercise weekly [1]. Whilst tirzepatide significantly reduces appetite and food intake independently, patients who implement structured dietary changes and regular physical activity achieve superior long-term weight maintenance once treatment concludes [4].

When to Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain (particularly if radiating to the back, which may indicate pancreatitis), persistent vomiting preventing fluid intake, visual changes, or signs of allergic reaction [1]. Contact your Cured Pharmacy prescriber for non-urgent concerns like ongoing nausea beyond the first week of a new dose, constipation lasting more than three days, or questions about dose progression timing. Most side effects are manageable with supportive measures and don't require treatment discontinuation [2].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro (tirzepatide) is a prescription-only medicine and must be prescribed following consultation with a registered UK clinician. Individual results may vary, and weight loss outcomes depend on adherence to treatment, lifestyle modifications, and individual metabolic factors.